Public Profile

Dynavax

Dynavax Technologies Corporation, commonly known as Dynavax, is a prominent biopharmaceutical company headquartered in the United States. Founded in 1996, the company has established itself in the immunotherapy sector, focusing on the development of innovative vaccines and therapeutics. With a strong emphasis on harnessing the power of the immune system, Dynavax's core products include HEPLISAV-B, a unique hepatitis B vaccine that offers enhanced protection with a two-dose regimen. This product distinguishes itself through its ability to provide rapid and long-lasting immunity. Dynavax has achieved significant milestones, including successful partnerships and a robust pipeline of immuno-oncology candidates, positioning itself as a leader in the biopharmaceutical industry. The company continues to make strides in advancing public health through its cutting-edge research and development efforts.

DitchCarbon Score

How does Dynavax's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

3

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

8

Industry Benchmark

Dynavax's score of 3 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.

55%

Dynavax's reported carbon emissions

Dynavax, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the absence of reported emissions may indicate a nascent stage in their sustainability journey or a focus on developing future climate strategies. As the biopharmaceutical industry increasingly prioritises environmental responsibility, Dynavax may be expected to align with industry standards and set measurable climate commitments in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Dynavax's primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Dynavax is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Dynavax is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Research Services

Infinite Roots

DE
Research Services
Updated 3 days ago

Exact Sciences

US
Research Services
Updated 11 days ago

Go North

SE
Research Services
Updated 11 days ago

TCTC

TW
Research Services
Updated 11 days ago

Frontiers in Public Health

CH
Research Services
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers